Results 281 to 290 of about 24,309,158 (381)

Can Endothelin-1 Help Address the Diagnostic and Prognostic Challenges in Multimorbid Acute Heart Failure Patients? [PDF]

Life (Basel)
Dmour BA, Badescu MC, Tuchiluș C, Cianga CM, Constantinescu D, Dima N, Duca ȘT, Dmour A, Costache AD, Cepoi MR, Crișan A, Leancă SA, Loghin C, Șerban IL, Costache-Enache II.   +14 more
europepmc   +1 more source

Modulation by Endothelin-1 of Spontaneous Activity and Membrane Currents of Atrioventricular Node Myocytes from the Rabbit Heart

, 2012
Stéphanie C.M. Choisy, Hongwei Cheng, Godfrey L. Smith, Andrew F. James, Jules C. Hancox   +4 more
openalex   +2 more sources

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 58-72, January 2026.
Aerospace medicine required controlled terrestrial models to investigate influences of altered atmosphere conditions, such as hypoxia, on human health and performance. These models could potentially be expanded to encompass disease conditions or treatment targets regulated through hypoxia or hypercapnia.
Titiaan E. Post, Cayla Denney, Adam Cohen, Jens Jordan, Ulrich Limper   +4 more
wiley   +1 more source

Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy. [PDF]

Sci Rep
Feriel B, Alessandra C, Deborah GJ, Corinne N, Raphaël T, Mina O, Ali A, Jean-Baptiste M, Guillaume F, Julien G, Maria-Rosa G, Elie F, Laurent S, Olaf M, Ly T, Marc H, Christophe G.   +16 more
europepmc   +1 more source

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Journal of Clinical Investigation, 1998
O. Hernández-Perera, D. Pérez-Sala, J. Navarro-Antolín, R. Sánchez-Pascuala, G. Hérnandez, Cristina Díaz, S. Lamas   +6 more
semanticscholar   +1 more source

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 16-26, January 2026.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

Plasma endothelin-1 levels in patients with rotator cuff tear: a case-control study. [PDF]

Ann Jt
Gumina S, De Marco A, Rosa P, Cantore M, Bastianelli D, Scibetta S, Calogero A, Candela V.   +7 more
europepmc   +1 more source

New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus.

Life Science, 2012
J. Pernow, A. Shemyakin, F. Böhm
semanticscholar   +1 more source

Role of endothelins [PDF]

, 1998
Bilzer, Manfred, Gerbes, Alexander L., Gülberg, Veit   +2 more
core   +1 more source

Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1

, 2015
Barbara Renga, Sabrina Cipriani, Adriana Carino, Michele Simonetti, Angela Zampella, Stefano Fiorucci   +5 more
openalex   +2 more sources